147 filings
Page 5 of 8
PRE 14A
48tlzoelt022imk34edb
14 Jun 19
Preliminary proxy
5:27pm
D/A
4w7k4619dh1zz5
29 May 19
$19.04M in equity, sold $19.04M, 25 investors
4:26pm
D
ekdkiav9njp
29 May 19
$19.04M in equity, sold $19.04M, 25 investors
3:24pm
8-K
r1p m1icumbjkonikf
20 May 19
CURE Pharmaceutical Expands Leadership Team with Key New Hires
4:39pm
NT 10-Q
vp9qe9
15 May 19
Notice of late quarterly filing
5:13pm
8-K
4f4bzh
14 May 19
Acquired Technology Expands Core CUREfilmTM Platform and Strengthens Balance Sheet
2:33pm
8-K
g5tdas
1 May 19
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
8:45am
RW
cggcczphqbqz
12 Apr 19
Registration withdrawal request
6:01am
8-K
7q0kw5
9 Apr 19
Departure of Directors or Certain Officers
3:32pm
8-K
hqonh
1 Apr 19
Entry into a Material Definitive Agreement
12:58pm
8-K
8kg24 41w
19 Feb 19
Departure of Directors or Certain Officers
4:22pm
8-K
p9ixuf 9o
17 Jan 19
Departure of Directors or Certain Officers
9:10am
8-K
ew6atf4ay
7 Jan 19
Entry into a Material Definitive Agreement
5:04pm
8-K
5k1r2s 34k
21 Dec 18
Entry into a Material Definitive Agreement
2:35pm
8-K/A
5hzh11
4 Dec 18
Departure of Directors or Certain Officers
4:38pm
8-K
d5w9gr1
23 Nov 18
Other Events
3:13pm
8-K
13lq73z1br8
20 Nov 18
Entry into a Material Definitive Agreement
4:09pm